Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Blocking FSH action attenuates osteoclastogenesis
Ling Ling Zhu
, Irina Tourkova
,
Tony Yuen
, Lisa J. Robinson
, Zhuan Bian
,
Mone Zaidi
, Harry C. Blair
Icahn School of Medicine at Mount Sinai
Institute for Translational Medicine and Pharmacology
Medicine
Medicine - Endocrinology, Diabetes and Bone Disease
Research output
:
Contribution to journal
›
Article
›
peer-review
60
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Blocking FSH action attenuates osteoclastogenesis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Osteoclastogenesis
100%
FSH Receptor
100%
Osteoclast
50%
Osteoclast Formation
50%
Monoclonal Antibody
25%
Linker
25%
Complementary DNA (cDNA)
25%
Binding Region
25%
Knockout Cells
25%
PCR Products
25%
Direct Sequencing
25%
Bone Turnover
25%
Signaling Domain
25%
Receptor Knockout
25%
Polyclonal Antibody
25%
Receptor Isoforms
25%
CD14+
25%
Osteoclast Precursors
25%
Exon 9
25%
Immunology and Microbiology
Osteoclast
100%
Osteoclastogenesis
100%
Precursor
66%
Monoclonal Antibody
33%
Exon
33%
CD14
33%
Bone Turnover
33%
Polyclonal Antibody
33%
Biochemistry, Genetics and Molecular Biology
Follicle-Stimulating Hormone
100%
Osteoclastogenesis
100%
Osteoclast
33%
Precursor
22%
Isoform
22%
Exon
11%
Monoclonal Antibody
11%
CD14
11%
Bone Turnover
11%
Polyclonal Antibody
11%